Skip to main content
MedPathMedPath Home
Clinical Trials/JPRN-UMIN000032596
JPRN-UMIN000032596
Recruiting
未知

Changes in respiratory status caused by nitrous oxide during general anesthesia - Changes in respiratory status caused by nitrous oxide during general anesthesia

Miyagi children's hospital0 sites5 target enrollmentMay 15, 2018
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsPatients who undergo general anesthesia

Overview

Phase
未知
Intervention
Not specified
Conditions
Patients who undergo general anesthesia
Sponsor
Miyagi children's hospital
Enrollment
5
Status
Recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 15, 2018
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Miyagi children's hospital

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • •1\. Patient who have cardiac, respiratory, or neuromuscular disease 2\. Patient who have upper respiratory infection 3\. Extraordinary operation

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Not Applicable
The Effects of Nitric Oxide for Inhalation on the Development of Chronic Lung Disease in Pre-term Infants.
EUCTR2004-002312-29-DEINO Therapeutics800
Active, not recruiting
Phase 1
The Effects of Nitric Oxide for Inhalation on the development of chronic lung disease in pre-term infants. - INOT-27Prevention of chronic lung disease in pre-term infants ( gestational age < 29 weeks) with respiratory distress.MedDRA version: 7.0 Level: LLT Classification code 10054933
EUCTR2004-002312-29-GBINO Therapeutics800
Active, not recruiting
Phase 1
The Effects of Nitric Oxide for Inhalation on the development of chronic lung disease in pre-term infants. - INOT-27Prevention of chronic lung disease in pre-term infants ( gestational age < 29 weeks) with respiratory distress.MedDRA version: 7.0Level: LLTClassification code 10054933
EUCTR2004-002312-29-FIINO Therapeutics800
Active, not recruiting
Not Applicable
The Effects of Nitric Oxide for Inhalation on the development of chronic lung disease in pre-term infants. - INOT-27
EUCTR2004-002312-29-ESINO Therapeutics600
Active, not recruiting
Not Applicable
The Effects of Nitric Oxide for Inhalation on the Development of Chronic Lung Disease in Pre-term InfantsPrevention of chronic lung disease in pre-term infants gestational age 29 weeks with respiratory distress.MedDRA version: 9.1Level: LLTClassification code 10028974Term: Neonatal respiratory distress syndrome
EUCTR2004-002312-29-ITINO THERAPEUTICS